930783-06-5

Upstream product

• 328-67-6 3-bromo-5-(trifluoromethyl)benzoic acid 
• 235097-95-7 [(2S)-2-(4-fluorophenyl)pent-4-en-1-yl]methylamine 
• 917572-25-9 3-bromo-N-[(2S)-2-(4-fluorophenyl)-4-oxobutyl]-N-methyl-5-(trifluoromethyl)benzamide 

Relevant academic research and scientific papers

MALEATE SALT OF 3-BROMO-N-{ (2S) -2- (4-F LUOROPHENYL) -4- [3- (4-ACETYLPIPERAZIN-1-YL) AZETIDIN-1-YL] BUTYL} -METHYL-5- (TRIFLUOROMETHYL)BENZAMIDE FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

The present invention relates to 3-bromo-N-{(2S)-2-(4-fluorophenyl)-4-[3-(4-acetylpiperazin-1-yl)azetidin-1-yl]butyl}-N-methyl-5-(trifluoromethyl)benzamide maleate and crystalline forms thereof. The present invention also relates to the use of said salt a

A FUMARATE SALT OF 3-BROMO-N-{ (2S) -2- (4 -FLUOROPHENYL) -4- [3- (4-ACETYLPIPERAZIN-L-YL) AZETIDIN-1-YL] BUTYL} -N-METHYL-5- (TRIFLUOROMETHYL)BENZAMIDE FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

The present invention relates to 3-bromo-N-{(2S)-2-(4-fluorophenyl)-4-[3-(4- acetylpiperazin-1-yl)azetidin-1-yl]butyl}-N-methyl-5-(trifluoromethyl)benzamide fumarate and crystalline forms thereof. The present invention also relates to the use of said salt

NOVEL AZETIDINE COMPOUNDS USEFUL IN THE TREATMENT OF FUNCTIONAL GASTROINTESTINAL DISORDERS, IBS AND FUNCTIONAL DYSPEPSIA

The present invention relates to new azetidine compounds, to pharmaceutical compositions cotaining them and the use of said compounds in in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia. The compounds are neurokinin